Trial intelligence / Profile preview

Dimethicone versus eucalyptus lotion for head lice in schoolgirls

IRCT20211211053349N2Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pediculosis capitis comparing 4% Dimethicone lotion with 4% Eucalyptus essential oil lotion (2 arms). Primary endpoint: Percentage of contamination. Started Sep 2022; status: completed.

02

Drugs

dimeticoneeucalyptus oil
03

Conditions

pediculosis capitis

Beyond the preview

Go deeper on IRCT20211211053349N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211211053349N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call